← Open Payments lookup

SAMUEL NIX: Open Payments

NPI 1780075473 · TEXARKANA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,485 in 78 payments from 15 companies in 2025. Trend: 2023 $1,591 · 2024 $1,075 · 2025 $1,485

Food & beverage: $1,485
CompanyPaymentsAmount
ABBVIE INC.22$301
AstraZeneca Pharmaceuticals LP14$282
Novo Nordisk Inc11$177
EVOKE PHARMA, INC.5$157
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$139
Bayer Healthcare Pharmaceuticals Inc.2$138
Amgen Inc.3$51
Boston Scientific Corporation2$48
Axsome Therapeutics, Inc.2$46
Boehringer Ingelheim Pharmaceuticals, Inc.2$45

Products named: UBRELVY, GIMOTI, BREZTRI, CAPLYTA, AIRSUPRA, Kerendia, Rybelsus, VRAYLAR.

Industry payments across AR — which companies pay providers there.